249 related articles for article (PubMed ID: 34996995)
1. Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.
Wang L; Liu X; Liu Z; Wang Y; Fan M; Yin J; Zhang Y; Ma Y; Luo J; Li R; Zhao X; Zhang P; Zhao L; Fan J; Chen Y; Lu W; Song X
Sci Rep; 2022 Jan; 12(1):192. PubMed ID: 34996995
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
Chen T; Yang C; Dou R; Xiong B
Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
[TBL] [Abstract][Full Text] [Related]
3. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
Front Immunol; 2022; 13():777724. PubMed ID: 35154101
[TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
8. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
9. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
10. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
11.
Fan Y; Ge Y; Niu K; Li Y; Qi LW; Zhu H; Ma G
Front Immunol; 2024; 15():1364329. PubMed ID: 38698844
[TBL] [Abstract][Full Text] [Related]
12. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
13. Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy.
Liu Z; Zhong J; Zeng J; Duan X; Lu J; Sun X; Liu Q; Liang Y; Lin Z; Zhong W; Wu W; Cai C; Zeng G
Front Immunol; 2021; 12():735170. PubMed ID: 34531875
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
Shi B; Qi J
J Cell Physiol; 2021 Apr; 236(4):2620-2630. PubMed ID: 32853461
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.
Ohandjo AQ; Liu Z; Dammer EB; Dill CD; Griffen TL; Carey KM; Hinton DE; Meller R; Lillard JW
Sci Rep; 2019 Oct; 9(1):14963. PubMed ID: 31628349
[TBL] [Abstract][Full Text] [Related]
16. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
Rui X; Shao S; Wang L; Leng J
BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
[TBL] [Abstract][Full Text] [Related]
17.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
18. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
Gong X; Ning B
Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528
[TBL] [Abstract][Full Text] [Related]
19. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
[TBL] [Abstract][Full Text] [Related]
20. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
